Stacy L. Taylor's most recent trade in Adaptive Biotechnologies Corp was a trade of 26,922 Common Stock done at an average price of $4.5 . Disclosure was reported to the exchange on Aug. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Aug 2024 | 26,922 | 139,365 (0%) | 0% | 4.5 | 121,079 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 60,010 | 60,010 | - | - | Stock Option (right to buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 39,990 | 179,668 (0%) | 0% | 0 | Common Stock | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 6,772 | 172,896 (0%) | 0% | 3.4 | 23,228 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 6,609 | 166,287 (0%) | 0% | 3.4 | 22,735 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 128,599 | 128,599 | - | - | Stock Option (right to buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 85,697 | 158,556 (0%) | 0% | 0 | Common Stock | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 13,387 | 139,678 (0%) | 0% | 8.6 | 115,128 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 06 Mar 2023 | 5,491 | 153,065 (0%) | 0% | 8.6 | 47,058 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 08 Mar 2022 | 2,387 | 72,859 (0%) | 0% | 11.4 | 27,307 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 154,448 | 154,448 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 61,779 | 76,815 (0%) | 0% | 0 | Common Stock | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2022 | 1,569 | 75,246 (0%) | 0% | 12.0 | 18,844 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 15,338 | 15,036 (0%) | 0% | 30 | 460,140 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 10,130 | 25,166 (0%) | 0% | 6.6 | 66,352 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 10,130 | 5,313 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 5,208 | 30,374 (0%) | 0% | 7.8 | 40,622 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 22 Dec 2021 | 5,208 | 17,709 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 07 Sep 2021 | 495 | 15,036 (0%) | 0% | 40 | 19,800 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 07 Sep 2021 | 495 | 15,443 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 07 Sep 2021 | 495 | 15,531 (0%) | 0% | 6.5 | 3,242 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 3,772 | 15,431 (0%) | 0% | 41.3 | 155,972 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,771 | 15,938 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,771 | 17,849 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,354 | 43,334 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,354 | 19,203 (0%) | 0% | 31.7 | 42,935 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,042 | 22,917 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 1,042 | 16,078 (0%) | 0% | 7.8 | 8,128 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Jun 2021 | 395 | 15,036 (0%) | 0% | 42.1 | 16,641 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 4,166 | 15,036 (0%) | 0% | 40 | 166,640 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,771 | 17,709 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,771 | 17,848 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,354 | 44,688 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,354 | 19,202 (0%) | 0% | 31.7 | 42,935 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,041 | 16,077 (0%) | 0% | 7.8 | 8,120 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 17 Jun 2021 | 1,041 | 23,959 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 4,166 | 15,036 (0%) | 0% | 41.9 | 174,680 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,770 | 19,480 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,770 | 17,848 (0%) | 0% | 6.6 | 11,594 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,354 | 19,202 (0%) | 0% | 31.7 | 42,935 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,354 | 46,042 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,042 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 30 Apr 2021 | 1,042 | 16,078 (0%) | 0% | 7.8 | 8,128 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2021 | 34,341 | 34,341 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2021 | 13,736 | 15,036 (0%) | 0% | 0 | Common Stock | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,771 | 4,112 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,771 | 23,021 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,333 | 1,300 (0%) | 0% | 56.4 | 75,181 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,079 | 3,033 (0%) | 0% | 54.5 | 58,773 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,041 | 2,341 (0%) | 0% | 7.8 | 8,120 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 1,041 | 27,084 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Feb 2021 | 400 | 2,633 (0%) | 0% | 55.5 | 22,184 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 16 Feb 2021 | 16,250 | 17,550 (0%) | 0% | 31.7 | 515,288 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 16 Feb 2021 | 16,250 | 48,750 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 16 Feb 2021 | 9,256 | 1,300 (0%) | 0% | 65.3 | 604,324 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 16 Feb 2021 | 4,894 | 12,656 (0%) | 0% | 63.4 | 310,426 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 16 Feb 2021 | 2,100 | 10,556 (0%) | 0% | 64.6 | 135,576 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,771 | 4,113 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,771 | 24,792 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,095 | 3,018 (0%) | 0% | 55.7 | 61,002 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,090 | 1,928 (0%) | 0% | 56.6 | 61,683 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,042 | 2,342 (0%) | 0% | 7.8 | 8,128 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 1,042 | 28,125 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 29 Jan 2021 | 628 | 1,300 (0%) | 0% | 57.8 | 36,273 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 4,759 | 29,167 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 4,759 | 6,059 (0%) | 0% | 7.8 | 37,120 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 4,529 | 3,301 (0%) | 0% | 57.5 | 260,599 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 1,771 | 7,830 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 1,771 | 26,563 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 1,610 | 1,691 (0%) | 0% | 58.4 | 94,024 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 31 Dec 2020 | 391 | 1,300 (0%) | 0% | 59.3 | 23,175 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 2,857 | 1,300 (0%) | 0% | 46.3 | 132,308 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 1,771 | 4,180 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 1,771 | 28,334 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 1,109 | 33,926 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 1,109 | 2,409 (0%) | 0% | 7.8 | 8,650 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 23 Nov 2020 | 23 | 4,157 (0%) | 0% | 45.7 | 1,051 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 2,262 | 1,300 (0%) | 0% | 50.0 | 113,010 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 1,770 | 30,105 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 1,770 | 4,180 (0%) | 0% | 6.6 | 11,594 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 1,110 | 2,410 (0%) | 0% | 7.8 | 8,658 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 1,110 | 35,035 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 26 Oct 2020 | 618 | 3,562 (0%) | 0% | 49.1 | 30,350 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 2,284 | 1,896 (0%) | 0% | 47.6 | 108,696 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 1,771 | 4,180 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 1,771 | 31,875 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 1,109 | 36,145 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 1,109 | 2,409 (0%) | 0% | 7.8 | 8,650 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Sep 2020 | 596 | 1,300 (0%) | 0% | 48.5 | 28,900 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,771 | 4,180 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,771 | 33,646 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,400 | 1,520 (0%) | 0% | 42.9 | 60,088 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,260 | 2,920 (0%) | 0% | 42.1 | 53,008 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,109 | 37,254 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 1,109 | 2,409 (0%) | 0% | 7.8 | 8,650 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Aug 2020 | 220 | 1,300 (0%) | 0% | 43.4 | 9,539 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Jul 2020 | 2,880 | 1,300 (0%) | 0% | 36.0 | 103,766 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Jul 2020 | 1,771 | 35,417 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Jul 2020 | 1,771 | 4,180 (0%) | 0% | 6.5 | 11,600 | Common Stock | |
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Jul 2020 | 1,109 | 38,363 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Stacy L. Taylor | SVP and General Counsel | 24 Jul 2020 | 1,109 | 2,409 (0%) | 0% | 7.8 | 8,650 | Common Stock |